Dance Biopharm Holdings Inc.

Giving Diabetes Patients Something to Dance About

Developing inhaled insulin products to break free from the shackles of injections or pills.

Transforming the treatment of diabetes

Transforming the treatment of diabetes

At Dance Biopharm, we focus on developing inhaled insulin products to treat diabetes patients worldwide. We began our operations in 2010 led by Dr. John Patton, who has over 20 years of experience in the development of inhaled insulin. Our team consists of experts in all aspects of inhaled insulin development and we are dedicated to creating a new generation of products that make inhaled insulin more compelling than ever.


Dance-501 is our investigational pocket-sized inhaler device that is designed to control prandial blood sugar in adults with diabetes.

View Dance-501